An Overview of Dengue Fever
Archives of Advances in Biosciences,
Vol. 15 No. 1 (2024),
24 January 2024
,
Page 1-24
https://doi.org/10.22037/aab.v15i1.44108
Abstract
Context: Dengue fever has been reported in 129 countries worldwide, including 100 countries in the Mediterranean region, South America, and Southeast Asia. It results in approximately 40,000 deaths each year, and there have been significant outbreaks of dengue fever in these areas in recent years. Approximately 50% of the global population is presently susceptible to acquiring the dengue virus, which is classified as an emerging and re-emerging ailment that is likely to impact several nations in the foreseeable future.
Evidence Acquisition: Despite the significant harm inflicted upon human health and the economic conditions of countries in recent years, dengue continues to be classified as a neglected disease, without the requisite attention and concerted efforts by countries to effectively manage it. Any actions taken in this domain are inherently constrained. Consequently, due to the significance of dengue fever, this study aims to comprehensively examine this matter.
Results: The disease used to be effectively managed in regions like the countries of the American continent and Singapore, but it has made a resurgence. Between 2008 and 2010, the number of cases in the regions of America, Southeast Asia, and the Western Pacific rose from 0.2 million to 2.2 million. These reports exclusively consist of officially documented sick cases. Multiple outbreaks have been documented in Asia, encompassing countries such as China, Pakistan, Taiwan, and Malaysia, as well as in South America, including Brazil and Mexico. Dengue fever cases have been documented in several Middle Eastern nations, including Yemen, Saudi Arabia, and southern Iran. Local transmission of the disease has begun in Europe, with France and Croatia reporting cases of local transmission. Annually, a minimum of 500,000 individuals experience serious illnesses requiring hospitalization. Approximately 2.5% of individuals who contract the condition die from it. Every year, numerous severe cases of dengue fever are documented, resulting in at least 20,000 deaths.
Conclusion: Dengue fever is a complex systemic disease. Assessing the complete range of the disease burden of dengue fever will be crucial to properly comprehend the serious medical and economic repercussions it has on patients and the general public.
- Dengue Fever
- Emerging and Reemerging Diseases
- Viral hemorrhagic Fever
How to Cite
References
Whitehorn J, Farrar J. Dengue. Br Med Bull. 2010;95:161-73. [DOI: 10.1093/bmb/ldq019] [PMID]
Whitehorn J, Farrar J. Dengue: Transmission, Diagnosis & Surveillance. Future Medicine Limited. 2014. [DOI:10.2217/ebo.13.743]
WHO. Global Strategy For Dengue prevention and Control, 2010-2020. Vector Ecology and Management Unit Department of Control of Neglected Tropical Diseases World Health Organization. 2012. [Link]
Khalili M, Aflatoonian MR, Hemati M, Mostafavi E, Aflatoonian B. Dengue fever serology in febrile patients in Southeast Iran. Journal of Kerman University of Medical Sciences. 2019;26(1):90-4. [DOI: 10.22062/jkmu.2019.87278]
Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in India. Dengue in India. Indian J Med Res. 2012;136(3):373-90. [PMID] [PMCID]
Sheet WF. Dengue and severe dengue. WHO; 2023. [Link]
Neyts J, Leyssen P, De Clercq E. Infections with faviviridae. Verh K Acad Voor Geneeskd Van Belg. 1999;61(6):661–97. [PMID]
Chen R, Vasilakis N. Dengue—Quo tu et quo vadis? Viruses. 2011;3(9):1562-608. [DOI: 10.3390/v3091562] [PMID] [PMCID]
Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, et al. Strategies for development of dengue virus inhibitors. Antiviral Res. 2010;85(3):450-62. [DOI: 10.1016/j.antiviral.2009.12.011] [PMID]
Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol. 2021;67(10):687-702. [DOI: 10.1139/cjm-2020-0572] [PMID]
Newton ND, Hardy JM, Modhiran N, Hugo LE, Amarilla AA, Bibby S, et al. The structure of an infectious immature favivirus redefnes viral architecture and maturation. Sci Adv. 2021;7(20):eabe4507. [DOI: 10.1126/sciadv.abe4507] [PMID]
Pierson TC, Diamond MS. Degrees of maturity: the complex structure and biology of faviviruses. Curr Opin Virol. 2012;2(2):168-75. [DOI: 10.1016/j.coviro.2012.02.011] [PMID] [PMCID]
Goncalvez AP, Escalante AA, Pujol FH, Ludert JE, Tovar D, Salas RA, et al. Diversity and evolution of the envelope gene of dengue virus type 1. Virology. 2002;303(1):110-9. [DOI: 10.1006/viro.2002.1686] [PMID]
Waman VP, Kolekar P, Ramtirthkar MR, Kale MM, Kulkarni-Kale U. Analysis of genotype diversity and evolution of Dengue virus serotype 2 using complete genomes. PeerJ. 2016;4:e2326. [DOI: 10.7717/peerj.2326] [PMID] [PMCID]
Nedjadi T, El-Kafrawy S, Sohrab SS, Despres P, Damanhouri G, Azhar E. Tacklingdengue fever: current status and challenges. Virol J. 2015;12:212. [DOI: 10.1186/s12985-015-0444-8] [PMID] [PMCID]
Braks MAH, Honório NA, Lourenço-De-Oliveira R, Juliano SA, Lounibos LP.Convergent habitat segregation of Aedes aegypti and Aedes albopictus (Diptera:Culicidae) in southeastern Brazil and Florida. J Med Entomol. 2003;40(6):785-94. [DOI: 10.1603/0022-2585-40.6.785] [PMID]
Gunara NP, Joelianto E, Ahmad I. Identification of Aedes aegypti and Aedes albopictus eggs based on image processing and elliptic fourier analysis. Sci Rep. 2023;13(1):17395. [DOI: 10.1038/s41598-023-28510-6] [PMID] [PMCID]
Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016;2:16055. [DOI: 10.1038/nrdp.2016.55] [PMID]
Locally acquired Dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep. 2010 May 21;59(19):577-81. [PMID]
Gubler DJ, Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res. 1999;53:35-70. [DOI: 10.1016/s0065-3527(08)60342-5] [PMID]
Azari-Hamidian S. Checklist of Iranian mosquitoes (Diptera: Culicidae). J Vector Ecol. 2007;32(2):235-42. [DOI: 10.3376/1081-1710(2007)32[235:coimdc]2.0.co;2] [PMID]
Khoshdel-Nezamiha F, Vatandoost H, AzariHamidian S, Bavani MM, Dabiri F, Entezar-Mahdi R, et al. Fauna and larval habitats of mosquitoes (Diptera: Culicidae) of West Azerbaijan Province, northwestern Iran. J Arthropod Borne Dis. 2014;8(2):163-73. [PMID]
Choumet V, Despres P. Dengue and other flavivirus infections. Rev Sci Tech. 2015;34(2):473-8. [PMID]
Alahmed AM, Munawar K, Khalil SMS, Harbach RE. Assessment and an updated list of the mosquitoes of Saudi Arabia. Parasit Vectors. 2019;12(1):356. [DOI: 10.1186/s13071-019-3579-4] [PMID] [PMCID]
Fakeeh M, Zaki AM. Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994-1999. Am J Trop Med Hyg. 2001;65(6):764-7. [DOI: 10.4269/ajtmh.2001.65.764] [PMID]
Al-Azab AM, Zaituon AA, Al-Ghamdi KM, Al-Galil FM. Surveillance of dengue fever vector Aedes aegypti in different areas in Jeddah city Saudi Arabia. Advances in Animal and Veterinary Sciences. 2022;10(2):348-53. [DOI: 10.17582/journal.aavs/2022/10.2.348.353]
Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33(4):330-42. [DOI: 10.1016/s0188-4409(02)00378-8] [PMID]
Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480-96. [DOI: 10.1128/CMR.11.3.480] [PMID] [PMCID]
Barrett AD, Stanberry LR. Vaccines for biodefense and emerging and neglected diseases. Academic Press; 2009. [Link]
Halstead SB. Dengue. Lancet. 2007;370(9599):1644-52. [DOI: 10.1016/S0140-6736(07)61687-0] [PMID]
Heilman JM, De Wolff J, Beards GM, Basden BJ. Dengue fever: a Wikipedia clinical review. Open Med. 2014;8(4):e105-15. [PMID] [PMCID]
Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990;3(4):376-96. [DOI: 10.1128/CMR.3.4.376] [PMID] [PMCID]
Guzman M, x, a G, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27(1):1-13. [DOI: 10.1016/s1386-6532(03)00010-6] [PMID]
Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol. 2021;67(10):687-702.
WHO Guidelines Approved by the Guidelines Review Committee. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva: World Health Organization Copyright © 2009, World Health Organization. 2009. [Link]
La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès P, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010;15(39):19676. [PMID]
Nguyen-Tien T, Do DC, Le XL, Dinh TH, Lindeborg M, Nguyen-Viet H, et al. Risk factors of dengue fever in an urban area in Vietnam: a case-control study. BMC Public Health. 2021;21(1):664. [DOI: 10.1186/s12889-021-10687-y] [PMID] [PMCID]
Cuong HQ, Hien NT, Duong TN, Phong TV, Cam NN, Farrar J, et al. Quantifying the emergence of dengue in Hanoi, Vietnam:1998–2009. PLoS Negl Trop Dis. 2011;5(9):e1322. [DOI: 10.1371/journal.pntd.0001322] [PMID]
Toan DTT, Hu W, Quang Thai P, Hoat LN, Wright P, Martens P. Hot spot detection and spatio-temporal dispersion of dengue fever in Hanoi. Glob Health Action. 2013;6:18632. [DOI: 10.3402/gha.v6i0.18632] [PMID] [PMCID]
Fakeeh M, Zaki AM. Dengue in Jeddah, Saudi Arabia, 1994-2002. Dengue Bulletin;2003;27:13-18. [Link]
Sowilem MM, Kamal HA, Khater EI. Life table characteristics of Aedes aegypti(Diptera:Culicidae) from Saudi Arabia. Trop Biomed. 2013;30(2):301-14. [PMID]
Aziz AT, Al-Shami SA, Mahyoub JA, Hatabbi M, Ahmad AH, Rawi CSM. An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito. Parasit Vectors. 2014;7:258. [DOI: 10.1186/1756-3305-7-258] [PMID] [PMCID]
Altassan KK, Morin C, Shocket MS, Ebi K, Hess J. Dengue fever in Saudi Arabia: A review of environmental and population factors impacting emergence and spread. Travel Med Infect Dis. 2019;30:46-53. [DOI: 10.1016/j.tmaid.2019.04.006] [PMID]
Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, et al. The global distribution of the arbovirus vectors Aedes aegyptiand Ae. albopictus. Elife. 2015;4:e08347. [DOI: 10.7554/eLife.08347] [PMID] [PMCID]
Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, et al. The global compendium of Aedes aegyptiand Ae. albopictusoccurrence. Sci Data. 2015;2:150035. [DOI: 10.1038/sdata.2015.35] [PMID] [PMCID]
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. [DOI: 10.1038/nature12060] [PMID] [PMCID]
Chew CH, Woon YL, Amin F, Adnan TH, Abdul Wahab AH, Ahmad ZE, et al. Rural-urban comparisons of dengue seroprevalence in Malaysia. BMC Public Health. 2016;16(1):824. [DOI: 10.1186/s12889-016-3496-9] [PMID]
Degife LH, Worku Y, Belay D, Bekele A, Hailemariam Z. Factors associated with dengue fever outbreak in Dire Dawa administration city, October 2015, Ethiopia—case control study. BMC Public Health. 2019;19(1):650. [DOI: 10.1186/s12889-019-7015-7] [PMID] [PMCID]
Gutu MA, Bekele A, Seid Y, Mohammed Y, Gemechu F, Woyessa AB, et al. Another dengue fever outbreak in Eastern Ethiopia-An emerging public health threat. PLoS Negl Trop Dis. 2021;15(1):e0008992. [DOI: 10.1371/journal.pntd.0008992] [PMID]
Mohammed Y. Epidemiology of Dengue Fever in Ethiopian Somali Region: Retrospective Health Facility Based Study. Central African Journal of Public Health. 2016;2:6. [DOI: 10.11648/j.cajph.20160202.12]
WHO. WHO supports Ethiopia’s response to a dengue fever outbreak in Somali Region. WHO; 2021. [Link]
Control ECfDPa. Dengue virus disease cases reported January–December 2022 European Centre for Disease Prevention and Control; 2023. [Link]
Meltzer MI, Rigau-Pérez JG, Clark GG, Reiter P, Gubler DJ. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. Am J Trop Med Hyg. 1998;59(2):265-71. [DOI: 10.4269/ajtmh.1998.59.265] [PMID]
Quam MB, Sessions O, Kamaraj US, Rocklov J, Wilder-Smith A. Dissecting Japan's Dengue Outbreak in 2014. Am J Trop Med Hyg. 2016;94(2):409-12. [DOI: 10.4269/ajtmh.15-0468] [PMID]
Tahir U, Khan UH, Zubair MS, Bahar EM. Wolbachia pipientis: A potential candidate for combating and eradicating dengue epidemics in Pakistan. Asian Pac J Trop Med. 2015;8(12):989-98. [DOI: 10.1016/j.apjtm.2015.11.012] [PMID]
Hashemi T. Incidence of dengue fever and risk of its transmission to the Afghan travelers to tropical regions: A discussion paper. Journal of Inventions in Biomedical and Pharmaceutical Sciences. 2020;5(3):27-30. [DOI: 10.26452/jibps.v5i3.1438]
Messina JP, Brady OJ, Pigott DM, Golding N, Kraemer MU, Scott TW, et al. The many projected futures of dengue. Nat Rev Microbiol. 2015;13(4):230-9.
Heydari M, Metanat M, Rouzbeh-Far MA, Tabatabaei SM, Rakhshani M, Sepehri-Rad N, et al. Dengue fever as an emerging infection in southeast Iran. Am J Trop Med Hyg. 2018;98(5):1469-71. [DOI: 10.4269/ajtmh.17-0634] [PMID]
Azizi K, Soltani A, Hashemi SA, Dorzaban H, RT-PCR assessment of mosquitoes of the genus Aedes for natural infection with the arbovirus causing dengue fever across Hormozgan Province, Iran, during 2017. 2ndInternational Congress of Vector-Borne Diseases & Climate Change;4thNational Congress of Medical Medical Entomology.Shiraz University of Medical Sciences, Shiraz, IRAN. 2019. [Link]
Chinikar S, SHah-hosseini N, Moradi M, Khakifirouz S, Rasi varaie F, Rafigh M, et al. The role of travelers in the epidemiology of Dengue Fever in Iran. 9th Asia Pacific Travel Health Conference. 2012. [Link]
Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol. 2021;78(1):17-32. [DOI: 10.1007/s00284-020-02284-w] [PMID] [PMCID]
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16. [DOI: 10.1038/nrmicro2460] [PMID] [PMCID]
Sellahewa KH. Pathogenesis of dengue haemorrhagic fever and its impact on case management. ISRN Infect Dis [Internet]. 2013;2013:1–6. [DOI: 10.5402/2013/571646]
Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19(5):429-36. [DOI: 10.1097/01.qco.0000244047.31135.fa] [PMID]
Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4):564-81. [DOI: 10.1128/CMR.00035-09] [PMID] [PMCID]
[66] Begum F, Das S, Mukherjee D, Mal S, Ray U. Insight into the tropism of dengue virus in humans. Viruses. 2019;11(12):1136. [DOI: 10.3390/v11121136] [PMID] [PMCID]
Nachman RL, Rafi S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359(12):1261-70. [DOI: 10.1056/NEJMra0800887] [PMID] [PMCID]
Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445-59. [DOI: 10.1007/s00705-013-1645-3] [PMID]
Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010;67(16):2773-86. [DOI: 10.1007/s00018-010-0357-z] [PMID]
CDC. Symptoms and Treatment. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD); 2021. [Link]
Gubler D. Prevention and Control of Aedes aegypti-borne Diseases: Lesson Learned from Past Successes and Failures. Asia-Pacific Journal of Molecular Biology and Biotechnology. 2013;19(3):111-4. [Link]
da Silva NS, Undurraga EA, Verro AT, Nogueira ML. Comparison between the traditional (1997) and revised (2009) WHO classifcations of dengue disease: a retrospective study of 30 670 patients. Trop Med Int Health. 2018;23(12):1282-93. [DOI: 10.1111/tmi.13155] [PMID]
Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev. 2008;225:300-13. [DOI: 10.1111/j.1600-065X.2008.00678.x] [PMID]
Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;9(7):921-7. [DOI: 10.1038/nm887] [PMID]
Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, et al. Cost-effectiveness of a Pediatric Dengue Vaccine. Vaccine. 2004;22(9-10):1275-80. [DOI: 10.1016/j.vaccine.2003.09.019] [PMID]
CDC. Dengue: Healthcare-providers: diagnosis. Centres for Disease Control and Prevention. 2019. [Link]
De Iani FCM, Caetano ACB, Cocovich JCW, Amâncio FF, Pereira MA, Adelino TÉR, et al. Dengue diagnostics: serious inaccuracies are likely to occur if pre-analytical conditions are not strictly followed. Mem Inst Oswaldo Cruz. 2021;115:e200287. [DOI: 10.1590/0074-02760200287] [PMID] [PMCID]
WHO. Laboratory testing for Zika virus and dengue virus infections: interim guidance. World Health Organization (WHO), Control of Neglected Tropical Diseases (NTD), Emergency Preparedness (WPE), Guidelines Review Committee. 2022. [Link]
Falconar AKI, de Plata E, Romero-Vivas CME. Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol. 2006;13(9):1044-51. [DOI: 10.1128/CVI.00105-06] [PMID] [PMCID]
Changal KH, Raina AH, Raina A, Raina M, Bashir R, Latief M, et al. Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India. BMC Infect Dis. 2016;16(1):715. [DOI: 10.1186/s12879-016-2053-6] [PMID] [PMCID]
LAM SK. Dengue Hemorrhagic Fever. Rev Med Microbial 1995;6:39-48. [Link]
Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med. 2011;12(1):90-100. [DOI: 10.1097/PCC.0b013e3181e911a7] [PMID]
Guidelines on Management of Dengue Fever & Dengue Haemorrhagic Fever In Children and Adolescents. In: Lanka MoHS, editor. Ministry of Health Sri Lanka In Collaboration with the Sri Lanka College of Paediatricians; 2012. [Link]
Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001;32(2):204-13. [DOI: 10.1086/318479] [PMID]
Rajapakse S, Rodrigo C, Rajapakse A. Treatment of dengue fever. Infect Drug Resist. 2012;5:103-12. [DOI: 10.2147/IDR.S22613] [PMID] [PMCID]
Thomas SJ, Endy TP. Critical issues in dengue vaccine development. Curr Opin Infect Dis. 2011;24(5):442-50. [DOI: 10.1097/QCO.0b013e32834a1b0b] [PMID]
Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A. Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses. Viruses. 2021;13(10):1967. [DOI: 10.3390/v13101967] [PMID] [PMCID]
Rothman AL. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol. 2010;338:83-98. [DOI: 10.1007/978-3-642-02215-9_7] [PMID]
De Silva AM, Harris E. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials. Cold Spring Harb Perspect Biol. 2018;10(6):a029371. [DOI: 10.1101/cshperspect.a029371] [PMID]
Hou J, Ye W, Chen J. Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines. Front Immunol. 2022;13:840104. [DOI: 10.3389/fimmu.2022.840104] [PMID]
Lin CC, Huang YH, Shu PY. Characteristic of dengue disease in Taiwan. Am J Trop Med Hyg. 2010;82(4):731-9. [DOI: 10.4269/ajtmh.2010.09-0549] [PMID]
Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38(2):411-9. [DOI: 10.4269/ajtmh.1988.38.411] [PMID]
Raviprakash K, Defang G, Burgess T, Porter K. Advances in dengue vaccine development. Hum Vaccin. 2009;5(8):520-8. [DOI: 10.4161/hv.5.8.9008] [PMID]
Chen L, Ewing D, Subramanian H, et al. A heterologous DNA primeVenezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. J Virol. 2007;81(21):11634-9. [DOI: 10.1128/JVI.00996-07] [PMID] [PMCID]
Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, et al. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. Virology. 2006;353(1):166-73. [DOI: 10.1016/j.virol.2006.05.005] [PMID]
Thomas SJ. The necessity and quandaries of dengue vaccine development. J Infect Dis. 2011;203:299–303. [DOI: 10.1093/infdis/jiq060] [PMID]
Izmirly AM, Alturki SO, Alturki SO, Connors J, Haddad EK. Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. Front Immunol. 2020;11:1055. [DOI: 10.3389/fimmu.2020.01055] [PMID]
Nikookar SH, Fazeli Dinan M, Zaim M, Enayati A. Prevention and Control Policies of Dengue Vectors (Aedes aegypti and Aedes albopictus) in Iran. Iranian Journal of Health Sciences. 2023;11(3):143-56. [DOI: 10.32598/ijhs.11.3.701.1]
Wu JY, Lun ZR, James AA, Chen XG. Dengue fever in mainland China. Am J Trop Med Hyg. 2010;83(3):664-71. [DOI: 10.4269/ajtmh.2010.09-0755] [PMID] [PMCID]
WHO. lobal vector control response 2017–2030. World Helath Organization, Control of Neglected Tropical Diseases (NTD), Global Malaria Programme (GMP), High Impact Epidemics, Vector Control and Resistance 2017. [Link]
Parks W, Lloyd L. Planning social mobilization and communication for dengue fever prevention and control: a step-by-step guide. World Health Organization; 2004. [Link]
- Abstract Viewed: 496 times
- pdf Downloaded: 329 times